id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
584243,f18cb41d-e309-4dd7-8753-77af83ceb53f,Q2,FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC),86196,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA),2008,second_quarter,PHA,Monitor legislative developments in health care,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2008-03-23T11:31:28-04:00
621019,2a796c06-6cc8-4bee-a132-519bdfc43ac8,Q2,"MAYBERRY & ASSOCIATES, LLC",51968,PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION,2008,second_quarter,PHA,"Food, Drug and Cosmetic Act","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2008-06-20T14:20:05-04:00
621023,067e30e2-44a0-43a2-adf8-3e2a0b9c02db,Q2,"MAYBERRY & ASSOCIATES, LLC",51968,HEALTHCARE COMPLIANCE PACKAGING COUNCIL,2008,second_quarter,PHA,Pharmaceutical regimen compliance.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2008-06-20T14:35:07-04:00
621120,2dd8d757-e570-4f1e-a6d6-a0ce6f4a651a,Q2,"ABELL, HENRY & ASSOCIATES, LLC",318378,EXPRESS SCRIPTS INCORPORATED,2008,second_quarter,PHA,DoD TRICARE Pharmacy Program,"Defense, Dept of (DOD)",,,0,0,2008-06-26T12:17:58-04:00
621338,d3956d50-c96d-4bba-80a3-ad849fa7d48f,Q2,"DUTKO WORLDWIDE, LLC",12868,IBIS BIOSCIENCES,2008,second_quarter,PHA,Counsel and advise client regarding attempts to secure federal procurement contracts for biosensor device.,"Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",10000,,0,0,2008-07-01T09:50:05-04:00
621352,5fb65109-c0e5-4ae9-b96f-dd08fe786ff9,Q2,"DUTKO WORLDWIDE, LLC",12868,NEWAYS INTERNATIONAL,2008,second_quarter,PHA,"Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly S. 762","Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-07-01T10:13:10-04:00
621594,6bc76ac6-dca7-45dd-837d-d367a4acc7e2,Q2,"CYBER SECURITY RESEARCH CONSULTANTS, LLC",91694,PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION,2008,second_quarter,PHA,Monitoring Dorgan/Snowe drug re-importation from Canada,"HOUSE OF REPRESENTATIVES,SENATE",14000,,0,0,2008-07-01T15:45:26-04:00
621623,dd6c5e08-8d25-4861-abdd-4f4da3d3b8e2,Q2,INDEPENDENT PHARMACY COOPERATIVE,313098,INDEPENDENT PHARMACY COOPERATIVE,2008,second_quarter,PHA,"S.1954 Requiring Medicare Prompt Payment of Claims, S.1951 AMP Fix legislation, H.R. 6331 Medicare Package, S. 1301 Medicare Package, H.R. 5839 directs the HHS Secretary to promulgate regulations to establish a drug identification and tracking system. H.R. 971 (Community Pharmacy Fairness Act)  Allowing pharmacy negotiations with payers.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2008-07-01T16:37:37-04:00
621774,e95481b2-cf36-44f6-971a-7fc8392d191b,Q2,"DUTKO WORLDWIDE, LLC",12868,MEDIMPACT HEALTHCARE SYSTEMS,2008,second_quarter,PHA,Work with CMS on the role of PBM's in delivering the Medicare Part D benefit and related operational issues.  Monitored a decision by CMS and POE and reporting for MedImpact.,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2008-07-02T13:48:23-04:00
621898,b21d60b5-05fa-4d96-84dc-b4c1be58af70,Q2,HOSPITAL SERVICE ASSOCIATION OF NORTHEASTERN PENNSYLVANIA,18683,HOSPITAL SERVICE ASSOCIATION OF NORTHEASTERN PENNSYLVANIA,2008,second_quarter,PHA,E-prescribing,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2008-07-03T09:31:11-04:00
622114,055e6c1f-3ee2-4731-bd92-ad8612b00c4c,Q2,MARSHALL BRACHMAN,6848,STEWART JACKSON PHARMACAL,2008,second_quarter,PHA,Senate HELP Committee and House Energy and Commerce Committee: monitor FDA legislation related to regulation of pharmaceutical manufacturing,"HOUSE OF REPRESENTATIVES,SENATE",6000,,0,0,2008-07-04T15:04:24-04:00
622474,fe431c33-4dc1-4965-adf2-2a6b547f4e11,Q2,INTERNATIONAL COMMERCE DEVELOPMENT CORP,286278,AMPHASTAR PHARMACEUTICALS INC,2008,second_quarter,PHA,Seeking generic pharmaceuticals approvals for client from the FDA and EPA.,"Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-07-07T16:38:10-04:00
623191,96647467-0665-43a6-bdb9-d6518756be2c,Q2,"RUBICON ADVISORS, LLC",315091,AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS,2008,second_quarter,PHA,"Healthcare:  centers for Medicare & Medicaid Services (CMS), Reimbursements",,30000,,0,0,2008-07-08T19:14:32-04:00
623192,d8f68837-8c31-4c5f-bde7-148344558216,Q2,"RUBICON ADVISORS, LLC",315091,FLEMING PHARMACEUTICALS,2008,second_quarter,PHA,"Healthcare:  Pharmaceuticals, Bioshield",,30000,,0,0,2008-07-08T19:20:33-04:00
623193,cf5e02aa-f8b4-4287-9cf3-8573d3eed6ab,Q2,"RUBICON ADVISORS, LLC",315091,GILEAD SCIENCES,2008,second_quarter,PHA,Healthcare:  Pharmaceuticals,,75000,,0,0,2008-07-08T19:25:34-04:00
623194,ce7df2df-3afc-4bca-9fdc-3f8fae53e812,Q2,"RUBICON ADVISORS, LLC",315091,TEVA PHARMACEUTICALS USA,2008,second_quarter,PHA,"Healthcare:  Pharmaceuticals, Prescription Drug User Fee",,90000,,0,0,2008-07-08T19:35:35-04:00
623195,72439a44-00a6-43e7-81f9-5b12ccb44260,Q2,"RUBICON ADVISORS, LLC",315091,WATSON PHARMACEUTICALS INC,2008,second_quarter,PHA,"Healthcare:  Pharmaceuticals, Prescription Drug User Fee",,102000,,0,0,2008-07-08T19:40:36-04:00
623196,7f14eafe-dd9a-48cf-99d0-0cb00f3355f7,Q2,"RUBICON ADVISORS, LLC",315091,INSMED INCORPORATED,2008,second_quarter,PHA,Pharmaceutical Issues,,22500,,0,0,2008-07-08T19:44:37-04:00
623301,31d342a3-8abc-4df0-b964-c44332f2fa35,Q2,CAPITOL HILL CONSULTING GROUP,72053,ASTELLAS PHARMA US,2008,second_quarter,PHA,"Pharmaceutical and life sciences, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; drug importation; and drug safety","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-07-09T10:37:18-04:00
623345,3bb3b09c-7cff-4291-9fe7-7079a38fc797,Q2,CAPITOL HILL CONSULTING GROUP,72053,DFB PHARMACEUTICALS INC,2008,second_quarter,PHA,General Pharmaceutical issues pertaining to the company,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-07-09T10:49:28-04:00
623354,29063c95-802c-4309-8fc6-96b3769330ed,Q2,CAPITOL HILL CONSULTING GROUP,72053,ELI LILLY AND COMPANY,2008,second_quarter,PHA,"General Pharmaceutical issues pertaining to Eli Lilly and Company, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; and drug importation","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2008-07-09T10:51:32-04:00
623420,edc0d6ea-a086-4fb9-997b-930437d02d57,Q2,CAPITOL HILL CONSULTING GROUP,72053,PHRMA,2008,second_quarter,PHA,"General pharmaceutical issues, including but not limited to: The Federal Food and Drug and Cosmetic Act; the Hatch-Waxman Act; patent reform; drug importation; and drug safety","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2008-07-09T11:15:55-04:00
623427,4fcd4d93-c2af-4e1a-8df9-b3181127946f,Q2,CAPITOL HILL CONSULTING GROUP,72053,PURDUE PHARMA LLP,2008,second_quarter,PHA,"General Pharmaceutical issues, including but not limited to: The Federal Food, Drug, and Cosmetic Act; The Controlled Drug Substances Act; Drug Imporation; and Drug Safety","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2008-07-09T11:16:57-04:00
623649,3cc59731-21bc-408f-92de-35d04af35478,Q2,OREGON HEALTH & SCIENCE UNIVERSITY,30291,OREGON HEALTH & SCIENCE UNIVERSITY,2008,second_quarter,PHA,Discounted Drug Prices for 340B Hospitals: Section 340B of the Public Health Services Act (HR 2606/S 1376).,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,41000,0,0,2008-07-09T13:37:37-04:00
624037,fc0adaa1-3fb1-4640-826b-0693d0552444,Q2,CAPITOL HILL CONSULTING GROUP,72053,NOVARTIS CORPORATION,2008,second_quarter,PHA,"Pharmaceutical and Life Sciences issues, including but not limited to: The Federal Food, Drug and Cosmetic Act; The Hatch-Waxman Act; drug safety","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2008-07-09T16:07:25-04:00
624211,534b1c2b-f639-45b9-aa65-1f652144c461,Q2,AMERICAN CAPITOL GROUP,305852,DISPENSING SOLUTIONS INC,2008,second_quarter,PHA,"Drug Improtation, Pharmacy, Counterfiet Drugs, HR 5839, The Safeguarding American's Pharmaceuticals Act","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2008-07-09T17:07:15-04:00
624557,6880fd5b-b708-4dfb-b928-874c65b45cb4,2T,"LIBERTY SQUARE DC, LLC",87335,AVENUE SOLUTIONS,2008,second_quarter,PHA,Prompt Pay for Pharmacists - insuring pharmacists receive payment in a timely manner,"HOUSE OF REPRESENTATIVES,SENATE",75000,,0,1,2008-07-10T11:12:59-04:00
624850,141d2a4a-26ac-4365-85a3-99c3a43cc405,Q2,PRICEWATERHOUSECOOPERS,10764,SCHERING-PLOUGH CORPORATION,2008,second_quarter,PHA,General issues affecting pharmaceutical companies,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2008-07-10T13:55:15-04:00
624886,b25dc2dc-1d08-42c9-aea3-aa8baa865e4a,Q2,HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA),28776,HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA),2008,second_quarter,PHA,"Importation of prescription drugs (H.R. 3161) (S. 1644)
Rx Pedigree (H.R. 5839)
Methamphetamine/Pseudoephedrine Regulation (S. 2071)
Internet Pharmacy (S. 980) (H.R. 6353)","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,235000,0,0,2008-07-10T14:23:29-04:00
625034,7487c545-12fd-4bf6-8655-dea4a598641a,2A,HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA),28776,HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA),2008,second_quarter,PHA,"Importation of prescription drugs (H.R. 3161) (S. 1644)
Rx Pedigree (H.R. 5839)
Methamphetamine/Pseudoephedrine Regulation (S. 2071)
Internet Pharmacy (S. 980) (H.R. 6353)","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,235000,0,0,2008-07-10T15:16:25-04:00
625162,2d54c3ae-78d2-47aa-9c63-793b4a1eac24,Q2,POLICY ADVOCATES,72018,PHOENIX CAPITAL MANAGEMENT LLC,2008,second_quarter,PHA,"S.980: Online Pharmacy Consumer Protection Act of 2007 - Track and monitor.
S.596: Safe Internet Pharmacy Act of 2007 - Track and monitor.
S.554: Act For Our Kids - Track and monitor.
HR 380: Pharmaceutical Market Access and Drug Safety Act of 2007 - Track and monitor. S. 242: Pharmaceutical Market Access and Drug Safety Act of 2007 - Track and monitor.","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2008-07-10T16:12:53-04:00
625411,8bf95052-e22a-4ea2-a9ba-8389f5e5f911,Q2,"MATTOON & ASSOCIATES, LLC",314215,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA,2008,second_quarter,PHA,"S2029 Physician Payments Sunshine Act - all provisions
HR 3610 Food and Drug Import Safety - provisions related to prescription drugs","HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2008-07-11T09:24:33-04:00
625854,bb81c05c-7efe-4943-92fc-0769ad3082c0,Q2,"CARDENAS PARTNERS, LLC",284573,SCHERING CORPORATION,2008,second_quarter,PHA,Seeking US Embassy support for American sales of pharmaceuticals in Latin America,"Drug Enforcement Administration (DEA),Office of Natl Drug Control Policy (NDCP),State, Dept of (DOS)",30000,,0,0,2008-07-11T14:17:43-04:00
625982,8bcbfe73-ddf2-4ccf-814b-dd6f85f732d8,Q2,APOTEX CORP.,310973,APOTEX CORP.,2008,second_quarter,PHA,"S 316, the Preserve Access to Affordable Generics Act
HR 1902, the Protecting Consumer Access to Generic Drugs Act
HR 1038, the Access to Life Saving Medicine Act
HR 5629, the Pathway for Biosimilars Act S 1695, the Biologics Price Competition and Innovation Act
HR 5839, the Safeguarding America's Pharmaceuticals Act
HR 3610, the Food and Drug Import Safety Act, Section 4, User Fees Regarding Drug Safety
Draft Senate food and drug import safety legislation
PL 110-85, the Food and Drug Amendments Act of 2007, Section 914, Citizen Petitions and petitions for stay of agency action
Combating anti-generic subsitution legislation in the states","HOUSE OF REPRESENTATIVES,SENATE",,130000,0,0,2008-07-11T15:41:41-04:00
626300,2862d8f0-a47a-4d40-a635-0f92b51678f2,Q2,"CGCN GROUP, LLC",76992,BARR PHARMACEUTICALS INC (FORMERLY BARR LABORATORIES INC ),2008,second_quarter,PHA,"H.R.3161, S.1859, Funding for the Office of Generic Drugs, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act H.R.2900, S.1082, Food and Drug Administration Reform","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-07-13T15:41:40-04:00
626617,7819cb68-1aed-4c8f-9a15-81bdc0a37ce9,Q2,BROYDRICK & ASSOCIATES,7268,BARR LABORATORIES,2008,second_quarter,PHA,"Patent reform, Generic Biologies","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2008-07-14T11:28:25-04:00
626710,88584d20-8d4f-4663-9024-84b5f603f30a,Q2,"APTIV, PLC",49054,APTIV PLC,2008,second_quarter,PHA,"Accessibility of generic drugs
e-prescriptions
Medical IT","Commerce, Dept of (DOC),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Federal Aviation Administration (FAA),Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Intl Trade Administration (ITA),Labor, Dept of (DOL),Natl Aeronautics & Space Administration (NASA),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,White House Office",,190000,0,0,2008-07-14T12:00:53-04:00
627025,c5747029-635c-4333-83ab-9fb9dc080145,Q2,GO DADDY.COM,303553,GO DADDY COM,2008,second_quarter,PHA,"S. 980 Controlled Substances Act
HR 6353 The Ryan Haight Online Pharmacy Consumer Protection Act of 2008","Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Natl Technical Information Service,Natl Telecommunications & Information Administration (NTIA),SENATE",,145000,0,0,2008-07-14T14:26:57-04:00
627968,d4ca2568-dc17-4143-9969-f34e039c9c70,Q2,STANTON PARK GROUP,83717,BARR LABORATORIES,2008,second_quarter,PHA,Generic Biologics HR 1956; S. 1695; HR 1038; S. 623; HR 5629; FDA Reform;,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-07-15T10:47:21-04:00
628103,1846ad2d-514a-40b2-ac01-681f6b45bd8d,Q2,UNIVERSITY OF CONNECTICUT,39382,UNIVERSITY OF CONNECTICUT,2008,second_quarter,PHA,"Implementation of Prescription Drug User Fee Amendments 2007 (Public Law 110-85), Drug safety related issues.","Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,70000,0,0,2008-07-15T11:15:09-04:00
628319,cc3d9acb-6b88-4113-b3ab-d4f9d07c4477,Q2,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",4653,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",2008,second_quarter,PHA,"S. 2311 and H.R. 4083, Non-Prescription Drug Modernization Act of 2007, provisions to grant the FDA authority over advertising for over-the-counter drugs
H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008, provisions imposing a three-year moratorium on prescription drug advertising and requiring fair balance in drug advertisemetns","Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE",,240000,0,0,2008-07-15T12:35:55-04:00
628399,9ce91e7c-bf42-475c-ae7e-6de3c5b5c63e,Q2,THE FRITTS GROUP,309275,CBS,2008,second_quarter,PHA,H.R. 1561 - Enhancing Drug Safety and Innovation Act of 2007,"HOUSE OF REPRESENTATIVES,SENATE",75000,,0,0,2008-07-15T13:04:11-04:00
628408,3f68a909-78a9-4a88-a69f-9c355a5047fb,Q2,THE FRITTS GROUP,309275,NEWS CORPORATION,2008,second_quarter,PHA,H.R. 1561 - Enhancing Drug Safety and Innovation Act of 2007,"HOUSE OF REPRESENTATIVES,SENATE",75000,,0,0,2008-07-15T13:07:16-04:00
628430,c40d32ea-a317-4ff5-875b-1ce329938287,Q2,MENTAL HEALTH AMERICA,28195,MENTAL HEALTH AMERICA,2008,second_quarter,PHA,"HR 6331;
Improvements to Medicare prescription drug law","HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,26103,0,0,2008-07-15T13:14:25-04:00
629032,f6d2109f-ae47-4f6c-96cd-1845c066c10c,Q2,"TIMMONS AND COMPANY, INC.",38164,TEVA PHARMACEUTICALS USA INC,2008,second_quarter,PHA,"S. 28 - To amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary.
S. 1505 - Affordable Biologics for Consumers Act. S. 1695 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes.
S. 242 - Pharmaceutical Market Access and Drug Safety Act of 2007.
S. 251 - Pharmaceutical Market Access Act of 2007.
S. 1082 - Prescription Drug User Fee Amendments of 2007.
H.R. 2900 - Food and Drug Administration Amendments Act of 2007.
H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act.
H.R. 1038 - Access to Life-Saving Medicine Act.
H.R. 5629 - Pathway for Biosimilars Act
H.R. 3610 - Food and Drug Import Safety Act of 2007 
H.R. 3624 - Consumer Food Safety Act of 2007","HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2008-07-15T16:19:28-04:00
629087,a53e8fa4-eb5f-40a7-b055-4f0afad4a902,Q2,BLUE CROSS BLUE SHIELD OF MICHIGAN,46676,BLUE CROSS BLUE SHIELD OF MICHIGAN,2008,second_quarter,PHA,"E- Prescribing; Comparative Effectiveness Research:  HR 3162 "" Children's Health and Medicare Protection Act of 2007""; HR 2184 ""Enhanced Health Care Value for All Act""","HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2008-07-15T16:39:12-04:00
629667,5846332f-315c-4e7e-8f82-4b0056ef65a8,Q2,UPS (UNITED PARCEL SERVICE),39223,UPS (UNITED PARCEL SERVICE),2008,second_quarter,PHA,Pedigree - pharmaceutical distribution,"Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),U.S. Customs & Border Protection,U.S. Trade Representative (USTR)",,1302504,0,0,2008-07-16T09:19:44-04:00
629699,ca51adf0-e4e1-4d94-8daf-84dee6969629,Q2,JAMES P. KEESE,74556,TEVA PHARMACEUTICALS USA,2008,second_quarter,PHA,"S. 623/Access to Life-Saving Medicine Act, S. 438/Fair Prescription Drug Competition Act, H.R. 806/Fair Prescription Drug Competition Act, H.R. 1956/Patient Protection and Innovative Biologic Medicines Act of 2007, H.R. 5629, H.R. 1038/Access to Life-Saving Medicine Act, S. 1505/Affordable Biologics for Consumers Act, S. 1695/Biologics Act of 2007, HR 3610","Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR)",40000,,0,0,2008-07-16T09:53:54-04:00
630124,37600d88-cd41-463c-b67c-14b9e464dc1a,Q2,"DEPARTMENT FOR PROFESSIONAL EMPLOYEES, AFL-CIO",12094,DEPARTMENT FOR PROFESSIONAL EMPLOYEES AFL-CIO,2008,second_quarter,PHA,- Support legislation to encourage biogeneric drugs,"HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2008-07-16T11:46:49-04:00
630524,d07fb7b8-0cc1-490f-b5ed-c7581a6b6d95,Q2,KEVIN MCGUINESS PLLC,299811,BARR LABS,2008,second_quarter,PHA,"Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics; S.623/H.R. 1032, Access to Life Saving Medicine Act","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2008-07-16T13:29:16-04:00
630600,6ee86065-d415-4e05-963d-7a6840d79976,Q2,UNIVERSITY OF PITTSBURGH MEDICAL CENTER,32065,UNIVERSITY OF PITTSBURGH MEDICAL CENTER,2008,second_quarter,PHA,Issues related to the cost of prescription pharmaceuticals and the impact of that cost on hospitals and health care providers.,"Air Force, Dept of,Army, Dept of (Other),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,260000,0,0,2008-07-16T13:48:37-04:00
630692,dc23cbd3-8d4a-4d01-8bd1-5920f099c263,Q2,MICHAEL POLLARD,87836,MEDCO HEALTH SOLUTIONS INC,2008,second_quarter,PHA,"HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects
HR 2970  - Pharmacy Benefit Manager Transparency Act of 2007; all aspects
HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects
HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects

S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects
S 251 - Pharmaceutical Market Access Act of 2007; all aspects
S 596 - Safe Internet Pharmacy Act of 2007; section 511(c)
S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects
S 2161 - Community Pharmacy Fairness Act of 2007; all aspects","Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",50000,,0,0,2008-07-16T14:02:58-04:00
630729,ad51507e-62b4-4d15-9bcd-69b98c6dbb51,Q2,AVENUE SOLUTIONS,72111,EXPRESS SCRIPTS INC,2008,second_quarter,PHA,Issues relating to prompt pay.,"HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2008-07-16T14:09:10-04:00
630744,1f9b8a4a-fefd-4cdf-ac17-3b5c44fbf01c,2A,CAPITOL HILL CONSULTING GROUP,72053,ASTELLAS PHARMA US,2008,second_quarter,PHA,"Pharmaceutical and life sciences, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; and drug safety","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-07-16T14:12:14-04:00
630753,566a6ea7-573a-4215-a643-bea028fe953b,Q2,AVENUE SOLUTIONS,72111,UNITEDHEALTH GROUP INC,2008,second_quarter,PHA,Issues relating to prompt pay.,"HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2008-07-16T14:13:17-04:00
630770,e8ecaace-c0b8-4e2a-a108-020312f57879,Q2,BLANK ROME GOVERNMENT RELATIONS,6325,ABBOTT LABORATORIES,2008,second_quarter,PHA,Issues related to hydrocodone,Drug Enforcement Administration (DEA),50000,,0,0,2008-07-16T14:19:22-04:00
630900,c94cfcd6-0eac-4f0f-9b9e-b4d89d735a97,Q2,VAN FLEET ASSOCIATES,39781,KIRK PHARMACEUTICALS,2008,second_quarter,PHA,FDA DEA regulations pertaining to over the counter drug sales.,"Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",9000,,0,0,2008-07-16T14:50:00-04:00
631573,52878409-867b-4343-9189-1059a11e7aeb,Q2,POLICY DIRECTIONS INC.,31747,ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ),2008,second_quarter,PHA,"Antibiotics in animal foods
Drug approvals 
S. 549/HR 962, all titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine.

S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA.

HR 3610 to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling.

Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act.

Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds.","Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2008-07-16T17:18:28-04:00
631620,e3f7bada-41a4-467e-b559-e1d8feecf822,Q2,"BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.",323876,BLUE CROSS AND BLUE SHIELD OF KANSAS INC,2008,second_quarter,PHA,"E-prescribing; Comparative Effectiveness Research:  HR3162 ""Children's Health and Medicare Protection Act of 2007"" Section 904 only; HR2184 ""Enhanced Health Care Value for All Act""","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2008-07-16T17:26:42-04:00
631747,9aec6462-19f8-40b1-9eb5-cc1568a2bad5,Q2,"PARRY, ROMANI, DECONCINI & SYMMS",30792,INTL ACADEMY OF COMPOUNDING PHARMACISTS,2008,second_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens (see next page). Support of H. Con. Res. 342, Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in House), and

Support of S. Con. Res. 88, Support of Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in Senate)","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2008-07-16T18:05:16-04:00
631997,92a3057b-5742-4bc1-9894-bcfa564336ab,Q2,"VERN CLARK & ASSOCIATES, INC.",9421,WILMER CUTLER PICKERING HALE & DORR (ON BEHALF OF THE MEDICINES COMPANY),2008,second_quarter,PHA,H.R. 6344 - Responsive Government Act of 2008 - patent issue.,SENATE,20000,,0,0,2008-07-16T21:02:32-04:00
632643,3f01a22f-c60b-4fcf-b80b-6cc225032556,Q2,"FLYNN & ASSOCIATES, INC.",15020,PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION,2008,second_quarter,PHA,"State Children's Health Insurance Program
Pharmaceutical industry employment issues
Intellectual Property law reform","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2008-07-17T10:21:17-04:00
632723,156bf0f4-daa4-414b-90ef-bd17d4e1e26d,Q2,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF CONNECTICUT,2008,second_quarter,PHA,"Implementation of Prescription Drug User Fee Amendments 2007 (Public Law 110-85), Drug safety related issues.","Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2008-07-17T10:30:43-04:00
632736,ae5c0103-7868-456c-a2e9-cfc0f2c40bd9,Q2,ACADEMY OF MANAGED CARE PHARMACY,48793,ACADEMY OF MANAGED CARE PHARMACY,2008,second_quarter,PHA,"Establishing a regulatory pathway for Food and Drug Administration approval of follow-on biologic products, electronic prescribing of controlled substances, regulation of online pharmacies, importation of prescription drugs","HOUSE OF REPRESENTATIVES,SENATE",,45000,0,0,2008-07-17T10:31:14-04:00
632747,484def37-7494-469c-84ef-f23d0028c0db,Q2,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF MARYLAND BALTIMORE,2008,second_quarter,PHA,"Implementation of Prescription Drug User Fee Amendments, 2007 (PL 110-85), Drug safety related issues.
H.R. 2900, Food and Drug Administration Amendments Act of 2007, drug safety related issues.","Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-07-17T10:31:47-04:00
632775,5b452f24-da1b-4380-b7a0-1947656d0c4a,Q2,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE,2008,second_quarter,PHA,"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2009, FDA and USDA funding initiatives.
Implementation of Prescription Drug User Fee Amendments, 2007 (Public Law 110-85), Drug safety related issues.
H.R. 3580, Food and Drug Administration Amendments Act of 2007, Drug safety and science related issues.","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2008-07-17T10:33:56-04:00
632793,b64860b4-1a17-4b16-a354-6cb5050a00d9,Q2,LATHAM & WATKINS LLP,22201,AMPHASTAR PHARMACEUTICALS,2008,second_quarter,PHA,"Congressional oversight of the Food and Drug Administration and Environmental Protection Agency
EPA rulemaking on CFC propellants","Environmental Protection Agency (EPA),Food & Drug Administration (FDA)",10000,,0,0,2008-07-17T10:36:03-04:00
632822,e3c45d57-f92a-421e-b2c7-c4f04d83ad3e,Q2,LATHAM & WATKINS LLP,22201,ORCHID CHEMICALS & PHARMACEUTICALS LTD,2008,second_quarter,PHA,Food and Drug Administration policy.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2008-07-17T10:42:09-04:00
632868,df777223-d31e-424a-ae90-fee6eaf66ddf,Q2,AMYLIN PHARMACEUTICALS,308536,AMYLIN PHARMACEUTICALS,2008,second_quarter,PHA,"H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics
H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions
H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics
S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics
S. 2029, Physician Payments Sunshine Act of 2007
S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions
S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Drug Importation
H.R., Pathway for Biosimilars Act
H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008","Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,495000,0,0,2008-07-17T10:47:56-04:00
632922,5f72fba7-89f2-4b7f-a5b1-84112f5e4f20,Q2,MCDERMOTT WILL & SCHULTE LLP,24338,RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION,2008,second_quarter,PHA,Amendments to Section 340(b) of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2008-07-17T10:55:06-04:00
633114,f63a7faa-1acd-4020-9998-416e992d31e0,Q2,"FIERCE, ISAKOWITZ & BLALOCK",44812,"MOMENTA PHARMACEUTICALS, INC.",2008,second_quarter,PHA,"Generic Biologics
Biologics: S.623/H.R.1038: Access to Life Saving Medicines Act
Biologics: H.R.5629: Pathway for Biosimilars Act
Biologics: S.1695: Biologics Price Competition and Innovation Act of 2007
Drug Safety as part of the Food and Drug Administration Globalization Act","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",20000,,0,0,2008-07-17T11:16:15-04:00
633343,f4f0b832-d00d-409d-ad85-fbcdfa17530a,Q2,"PARRY, ROMANI, DECONCINI & SYMMS",30792,SUNOVION PHARMACEUTICALS INC (FORMERLY SEPRACOR INC ),2008,second_quarter,PHA,No specific legislation or bills introduced at this time.  Medicare reimbursement issues.,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2008-07-17T11:58:42-04:00
633375,eff0cf37-1191-4bb2-a9ff-41761a139daf,Q2,KIRKLAND & ELLIS LLP,21745,TEVA PHARMACEUTICALS USA,2008,second_quarter,PHA,House and Senate legislation on biologic medicines.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2008-07-17T12:03:54-04:00
633669,8ecde963-aee0-4260-9e44-8d1138a51834,Q2,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,26672,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,2008,second_quarter,PHA,"See addendum. H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan.
H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program.
H.R.1038/S.623, Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals.
H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products.
H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program.
H.R.3140, Saving Our Community Pharmacies Act, as related to Medicaid provider reimbursement.
H.R.3193, Access to Community Pharmacy Preservation Act, as related to Medicaid provider reimbursement.
H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program.
H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices.
H.R.5491, Emilys Act, as related to the certification of pharmacy technicians.
H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices.
H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program.
H.R.5629, Pathway for Biosimilars Act, as related to the availability of generic pharmaceuticals.
H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program.
H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals.
H.R.6252, Medicare DMEPOS Competitive Acquisition Reform Act of 2008, as related to provider participation in the Medicare competitive bidding program.
H.R.6331, the Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement, electronic health care, and Medicare programs.
H.R.6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies.
H.R.6357, PRO(TECH)T Act of 2008, as related to health information technology.
S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines.
S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies.
S.1693, Wired for Health Care Quality Act, as related to health information technology.
S.1695, the Biologics Price Competition and Innovation Act, as related to the approval of generic biopharmaceuticals.
S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program.
S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals.
S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program.
S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies.
S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program.
S.2071, Combat Methamphetamine Enhancement Act, as related to the distributio of legal substances used in the production of methamphetamine.
S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan.
S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program.
S.2978, Credit and Debit Card Receipt Clarification Act of 2008, as related to fair credit card practices
S.3001, National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program.
S.3086, Credit Card Fair Fee Act of 2008, as related to fair credit card practices.
S.3101, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement and electronic health care.","Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Natl Drug Control Policy (NDCP),President of the U.S.,SENATE",,420000,0,0,2008-07-17T13:23:38-04:00
634288,69895640-44ce-469a-8808-2305673cdeb6,Q2,THE ACCORD GROUP,42785,CIBA SPECIALTY CHEMICALS CORP,2008,second_quarter,PHA,Sucreen additives,"Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE,U.S. International Trade Commission (ITC)",37500,,0,0,2008-07-17T15:06:40-04:00
634344,bcd830fe-dffd-480b-9d2b-fb2ae5e5cf81,Q2,THE ACCORD GROUP,42785,CITIZENS FOR SUN PROTECTION,2008,second_quarter,PHA,Final promulgation of sunscreen monograph,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2008-07-17T15:14:00-04:00
634442,6b9d6c72-d610-4c40-bd69-610c67f8ec04,Q2,AMERICA'S ESSENTIAL HOSPITALS,27057,AMERICA'S ESSENTIAL HOSPITALS,2008,second_quarter,PHA,"H.R. 2606/S. 1376, 340B Program Improvement and Integrity Act of 2007","HOUSE OF REPRESENTATIVES,SENATE",,405000,0,0,2008-07-17T15:19:24-04:00
634539,acbdb320-4b44-4e0b-bb68-a5746698e751,Q2,SHIRE PHARMACEUTICALS LLC,323477,SHIRE PHARMACEUTICALS LLC,2008,second_quarter,PHA,Biosimilars legislation; orphan provisions; ADHD,"HOUSE OF REPRESENTATIVES,SENATE",,120000,0,0,2008-07-17T15:30:17-04:00
634719,d9c0a43f-f5f6-4409-94a5-339a723dbde1,Q2,THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES),9237,THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES),2008,second_quarter,PHA,"S.1505, Affordable Biologics for Consumers Act (Gregg)
Issues relating to long term safety and effectiveness of medical devices and drugs.","Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of",,210000,0,0,2008-07-17T15:41:09-04:00
634773,28cd3e29-6a1f-47d8-b1f0-e778a0895d5f,Q2,"TARPLIN, DOWNS & YOUNG, LLC",304736,HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.),2008,second_quarter,PHA,"**see addendum page Importation of prescription drugs (H.R. 3161) (S. 1644)
Rx Pedigree (H.R. 5839)
Methamphetamine/Pseudoephedrine Regulation (S. 2071)
Internet Pharmacy (S. 980) (H.R. 6353)","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",60000,,0,0,2008-07-17T15:45:30-04:00
634844,6c7a81ca-8126-47c7-b6da-0b92aa3c2254,Q2,DUANE MORRIS GOVERNMENT AFFAIRS,49657,CB DISTRIBUTORS INC,2008,second_quarter,PHA,Regulation of over-the-counter asthma-cough medicines.,"Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2008-07-17T15:51:59-04:00
634887,d81136d9-a5b8-4697-9c4a-c978dca80c7c,Q2,"TARPLIN, DOWNS & YOUNG, LLC",304736,ADVAMED,2008,second_quarter,PHA,"Import Safety
     H.R. 3610 Food and Drug Import Safety Act of 2007

***no specific bills, Import Safety, Implementation of FDAAA, Preemption","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",60000,,0,0,2008-07-17T15:55:21-04:00
635257,9abe67b6-8597-4d5f-9276-a42ba01408f0,Q2,"FIERCE, ISAKOWITZ & BLALOCK",44812,MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES,2008,second_quarter,PHA,"Health Information Technology
S.1693: Wired for Health Care Quality Act
Anti-trust
H.R.971/S.2161: Community Pharmacy Fairness Act
Pharmacy Reimbursement
H.R.1474: Fair and Speedy Treatment of Medicare Drug Claims Act S.1954: Pharmacy Access Improvement Act of 2007","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",80000,,0,0,2008-07-17T16:27:41-04:00
635336,f1139721-1479-403b-b78d-f7af8e774ecc,Q2,"FIERCE, ISAKOWITZ & BLALOCK",44812,COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET,2008,second_quarter,PHA,"Biologics
S.623/H.R.1038: Access to Life Saving Medicines Act
H.R.5629: Pathway for Biosimilars Act
S.1695:, Biologics Price Competition and Innovation Act of 2007
State generic drug substitution laws","HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE",50000,,0,0,2008-07-17T16:33:18-04:00
635501,30375c34-43bd-4d2c-9fd0-7d833b4b7e3c,Q2,WINSTON & STRAWN LLP,41682,FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ),2008,second_quarter,PHA,Represent the client on issues related to assuring a safe supply of heparin.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2008-07-17T16:48:24-04:00
635698,bf0e8396-d6c5-4f4d-ae6d-402086dba718,Q2,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,27478,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,2008,second_quarter,PHA,"I.   HR 971, the ""Community Pharmacy Fairness Act of 2007""; S. 2161, the ""Community Pharmacy Fairness Act of 2007""; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the ""Medicare Prescription Drug Price Negotiation Act of 2007""; potential language not included in S. 2499, the ""Medicare, Medicaid and SCHIP Extension Act of 2007"" re e-prescribing; HR 1474, the ""Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the ""Safeguarding America's Pharmaceuticals Act of 2008,"" provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy;

II.       and also HR 3140, ""Saving Our Community Pharmacies Act of 2007""; S. 1951, the ""Fair Medicaid Drug Payment Act of 2007""; S. 1954, the ""Pharmacy Access Improvement (PhAIm) Act of 2007""; HR 3700, the ""Fair Medicaid Drug Payment Act of 2007""; Sec. 7002(b) of HR 2006 and PL 110-28, ""Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program"", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the ""PRO(TECH)T Act of 2008"", provisions impacting health technology requirements for pharmacies; HR 6331, the ""Medicare Improvements for Patients and Prviders Act of 2008,"" Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, 
all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.","Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,180000,0,0,2008-07-17T17:16:24-04:00
635829,7f0a37a5-d05d-4c59-ab8c-2ec249911d93,Q2,"JOHNSON & JOHNSON SERVICES, INC.",20686,JOHNSON & JOHNSON SERVICES INC,2008,second_quarter,PHA,"H.R. 2589, ""Improving Pharmaceuticals for Children Act of 2007,"" regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. S 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; S 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; S 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; HR 4083 / S 2311, ""Non-Prescription Drug Modernization Act of 2007,"" regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of mongraphs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; S 1951, ""Fair Medicaid Drug Payment Act of 2007,"" regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,1700000,0,0,2008-07-17T17:45:03-04:00
636012,dd9ec45b-6419-4305-9677-22fa4b174274,Q2,WINBORN SOLUTIONS LLC,308310,PERRIGO CO,2008,second_quarter,PHA,"Food and drug safety, user fee, and country of origin legislation","Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE",18000,,0,0,2008-07-17T18:19:40-04:00
636199,c1bb3d0d-52bb-469f-b41e-d05ff0f00692,Q2,WINSTON & STRAWN LLP,41682,BARR LABORATORIES INC,2008,second_quarter,PHA,Hatch - Waxman reform,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2008-07-17T19:26:05-04:00
636284,321f27a6-26cc-4294-9a22-ccb67c747538,Q2,MFJ INTERNATIONAL,59331,"TEVA PHARMACEUTICALS USA, INC.",2008,second_quarter,PHA,Trade issues and access to medicines.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2008-07-17T21:53:20-04:00
636286,7806d999-3a39-4438-879f-346b59c63f69,Q2,MFJ INTERNATIONAL,59331,GENERIC PHARMACEUTICAL ASSOCIATION,2008,second_quarter,PHA,Trade agreements and access to medicines.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2008-07-17T21:57:21-04:00
636612,3990f65d-73b0-438a-948e-d17572ec9b51,Q2,ASSOCIATION FOR ACCESSIBLE MEDICINES,16032,ASSOCIATION FOR ACCESSIBLE MEDICINES,2008,second_quarter,PHA,"Generic Biologics, including but not limited to: S.623, S.1505, S.1695, H.R.1038, H.R.1956, and H.R.5629
Prescription Drug Safety
Food and Drug Administration Amendments Act of 2007 (H.R.3580): any parts relating to access to generic drugs and the impact and marketing of prescription drugs Citizen Petitions, including but not limited to: S.25 and S.1088
Counterfeit Drugs/Import Safety/Pedigree
Electronic Prescribing (E-Prescribing)
Authorized Generics including but not limited to: S.2408 and H.R.4296
Prescription Drug Importation/Re-Importation
Any other matters that relates to access to generic drugs","Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE,Treasury, Dept of,U.S. Trade Representative (USTR),White House Office",,459139,0,0,2008-07-18T09:03:30-04:00
636654,0b881c99-49be-4c59-9351-84a3c61d811f,Q2,BGR GOVERNMENT AFFAIRS,5357,ADAMS RESPIRATORY THERAPEUTICS,2008,second_quarter,PHA,"Monitoring and guidance with regard to FDA enforcement action, DXM-related litigation","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-07-18T09:12:52-04:00
636726,f41615b6-684a-4b2f-bef5-56016fc43c03,Q2,US STRATEGIES,38825,NOVOLOGIX (FORMERLY ANCILLARY CARE MANAGEMENT),2008,second_quarter,PHA,Medicare and Medicaid provisions relating to pharmacy and medication management policies,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2008-07-18T09:28:08-04:00
637592,d5162114-cc85-49b7-bfd7-d6cb071f7e1d,Q2,"BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC.",6382,BLUE CROSS AND BLUE SHIELD OF FLORIDA INC,2008,second_quarter,PHA,E-Prescribing; Effectiveness Research,"HOUSE OF REPRESENTATIVES,SENATE",,340000,0,0,2008-07-18T11:12:05-04:00
637619,4f03f83d-ed1f-4215-b734-08470e78242d,Q2,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2008,second_quarter,PHA,Coverage for direct patient care services of qualified pharmacists under Medicare Part B.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,55950,0,0,2008-07-18T11:14:40-04:00
637840,6662fbfe-e544-496a-9ad3-39def882b7eb,Q2,"MARC ASSOCIATES, INC.",23747,AMERICAN SOCIETY OF HEMATOLOGY,2008,second_quarter,PHA,Oncology drug issues.,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2008-07-18T11:36:23-04:00
638242,5689320d-6f6e-4c51-8a66-18a9f411c005,Q2,"THE OB-C GROUP, LLC",29802,ELI LILLY,2008,second_quarter,PHA,"HR 5629, Pathway for Biosimilars Act: biologics.
S 1695, Biologics Price Competition and Innovation Act of 2007: biologics.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2008-07-18T12:10:21-04:00
638540,262178b5-3d11-4a04-b748-74026e1559aa,Q2,VENABLE LLP,39941,ENDO PHARMACEUTICALS INC,2008,second_quarter,PHA,General issues affecting the pharmaceutical industry.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2008-07-18T12:58:27-04:00
638564,019d799d-cea9-4b6d-8187-64fc69da39b5,Q2,BLUE CROSS AND BLUE SHIELD ASSOCIATION,6358,BLUE CROSS AND BLUE SHIELD ASSOCIATION,2008,second_quarter,PHA,"E-prescribing; Comparative Effectiveness Research:  HR3162 ""Children's Health and Medicare Protection Act of 2007"" Section 904 only; HR2184 ""Enhanced Health Care Value for All Act""","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,2400000,0,0,2008-07-18T13:01:15-04:00